This inventor holds 7 USPTO granted patents. Top assignees: Roche Diagnostics Gmbh, Boehringer Mannheim Gmbh. Active years: 1995-2007.
Location History:
- Munchen, DE (1995 - 2000)
- München, DE (2001)
- Munich, DE (1999 - 2007)
Company Filing History:
Years Active: 1995-2007
Title: Matthias Hinzpeter: Innovator in Monoclonal Antibodies
Introduction
Matthias Hinzpeter is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 7 patents to his name, his work has had a considerable impact on medical research and diagnostics.
Latest Patents
One of his latest patents involves monoclonal antibodies against the epitope YPYDVPDYA, which is derived from the haemagglutinin of the human influenza virus. This invention is crucial for the detection and isolation of native haemagglutinin, modified haemagglutinin, or haemagglutinin fusion proteins. The antibodies exhibit an impressive affinity of greater than 10M, specifically around 10 to 10M. Another significant patent pertains to a method of detecting telomerase activity, which is vital for cancer research and diagnostics.
Career Highlights
Throughout his career, Matthias has worked with prominent companies such as Roche Diagnostics GmbH and Boehringer Mannheim GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biotechnology.
Collaborations
Matthias has collaborated with esteemed colleagues, including Hermann Leying and Hans-Peter Fritton. These partnerships have further enhanced his research capabilities and have led to innovative advancements in his field.
Conclusion
Matthias Hinzpeter's contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies, demonstrate his commitment to advancing medical science. His work continues to influence research and diagnostics, making him a significant figure in the industry.